C13 H11 F3 N2 O4 S 348.298 N-{[(2S)-3-oxo-6-(trifluoromethyl)-3,4-dihydro-2H-1,4-benzothiazin-2-yl]acetyl}glycine N 0 Corina N 2025-08-22 7IP9 N 2026-05-15 RCSB REL HETAIN A1CQE non-polymer C1 0 -19.147 -22.774 14.585 1 Y C13 A1CQE N 2.633 -1.116 -1.328 1 N C C2 0 -20.386 -20.767 15.392 1 N C15 A1CQE N 4.510 -1.515 0.277 2 N C C3 0 -21.417 -24.331 14.823 1 Y C20 A1CQE N 1.736 1.055 0.165 3 N C C4 0 -22.722 -26.737 14.969 1 N C22 A1CQE N 0.119 2.726 0.865 4 N C C5 0 -21.260 -30.336 19.930 1 N C02 A1CQE N -5.533 -1.970 0.355 5 N C C6 0 -22.244 -29.296 19.397 1 N C04 A1CQE N -4.850 -0.834 -0.362 6 N C C7 0 -21.451 -28.514 17.151 1 N C06 A1CQE N -2.909 0.605 -0.045 7 N C C8 0 -20.730 -27.477 16.286 1 N C08 A1CQE N -1.706 1.047 0.747 8 N C C9 0 -21.329 -27.381 14.873 1 N C09 A1CQE N -1.012 2.200 0.018 9 S C C10 0 -20.222 -24.891 14.359 1 Y C11 A1CQE N 1.077 0.679 -1.006 10 N C C11 0 -19.082 -24.118 14.246 1 Y C12 A1CQE N 1.523 -0.405 -1.746 11 N C C12 0 -20.336 -22.234 15.054 1 Y C14 A1CQE N 3.298 -0.741 -0.175 12 N C C13 0 -21.480 -22.986 15.154 1 Y C19 A1CQE N 2.858 0.338 0.566 13 N C F1 0 -21.239 -20.181 14.522 1 N F16 A1CQE N 5.617 -0.661 0.325 14 N F F2 0 -19.146 -20.276 15.226 1 N F17 A1CQE N 4.275 -2.048 1.549 15 N F F3 0 -20.799 -20.529 16.657 1 N F18 A1CQE N 4.762 -2.554 -0.625 16 N F N1 0 -21.546 -28.317 18.584 1 N N05 A1CQE N -3.680 -0.404 0.407 17 N N N2 0 -22.728 -25.206 14.954 1 N N21 A1CQE N 1.308 2.135 0.931 18 N N O1 0 -20.022 -30.123 19.835 1 N O01 A1CQE N -5.088 -2.378 1.402 19 N O O2 0 -21.681 -31.398 20.468 1 N O03 A1CQE N -6.636 -2.528 -0.169 20 N O O3 0 -21.934 -29.479 16.654 1 N O07 A1CQE N -3.185 1.158 -1.089 21 N O O4 0 -23.735 -27.344 15.069 1 N O23 A1CQE N -0.071 3.724 1.527 22 N O S1 0 -20.170 -26.570 13.922 1 N S10 A1CQE N -0.321 1.605 -1.555 23 N S H1 0 -18.272 -22.148 14.484 1 N H1 A1CQE N 2.978 -1.965 -1.899 24 N H H2 0 -22.728 -28.787 20.243 1 N H2 A1CQE N -4.532 -1.167 -1.350 25 N H H3 0 -23.008 -29.798 18.785 1 N H3 A1CQE N -5.543 0.000 -0.465 26 N H H4 0 -19.670 -27.760 16.203 1 N H4 A1CQE N -2.023 1.380 1.735 27 N H H5 0 -20.810 -26.493 16.772 1 N H5 A1CQE N -1.012 0.213 0.850 28 N H H6 0 -21.432 -28.395 14.459 1 N H6 A1CQE N -1.730 2.999 -0.170 29 N H H7 0 -18.156 -24.553 13.900 1 N H7 A1CQE N 1.005 -0.693 -2.648 30 N H H8 0 -22.407 -22.541 15.483 1 N H8 A1CQE N 3.393 0.633 1.456 31 N H H9 0 -21.133 -27.512 19.010 1 N H9 A1CQE N -3.459 -0.846 1.242 32 N H H10 0 -23.607 -24.735 15.031 1 N H10 A1CQE N 1.939 2.492 1.576 33 N H H11 0 -20.943 -31.927 20.746 1 N H11 A1CQE N -7.039 -3.253 0.328 34 N H N 1 N sing N 2 N sing Y 3 N doub Y 4 N sing Y 5 N sing N 6 N sing Y 7 N doub N 8 N sing Y 9 N doub N 10 N sing N 11 N sing N 12 N sing N 13 N doub Y 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N doub N 20 N sing N 21 N sing N 22 N sing N 23 N doub N 24 N sing N 25 N sing N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N sing N 34 N sing N 35 N sing RCSB RCSB O=C(O)CNC(=O)CC1Sc2ccc(cc2NC1=O)C(F)(F)F InChI=1S/C13H11F3N2O4S/c14-13(15,16)6-1-2-8-7(3-6)18-12(22)9(23-8)4-10(19)17-5-11(20)21/h1-3,9H,4-5H2,(H,17,19)(H,18,22)(H,20,21)/t9-/m0/s1 QOZYXBALBJWXNK-VIFPVBQESA-N OC(=O)CNC(=O)C[C@@H]1Sc2ccc(cc2NC1=O)C(F)(F)F OC(=O)CNC(=O)C[CH]1Sc2ccc(cc2NC1=O)C(F)(F)F c1cc2c(cc1C(F)(F)F)NC(=O)[C@@H](S2)CC(=O)NCC(=O)O c1cc2c(cc1C(F)(F)F)NC(=O)C(S2)CC(=O)NCC(=O)O N-{[(2S)-3-oxo-6-(trifluoromethyl)-3,4-dihydro-2H-1,4-benzothiazin-2-yl]acetyl}glycine 2-[2-[(2~{S})-3-oxidanylidene-6-(trifluoromethyl)-4~{H}-1,4-benzothiazin-2-yl]ethanoylamino]ethanoic acid